Search

Your search keyword '"Mahmoud, Tala"' showing total 106 results
Start Over Author "Mahmoud, Tala" Language english
106 results on '"Mahmoud, Tala"'

3. A novel blood-sensing capsule for rapid detection of upper GI bleeding: a prospective clinical trial

Author

Akiki, Karl, Mahmoud, Tala, Alqaisieh, Mohammad H., Sayegh, Lea N., Lescalleet, Kristin E., Abu Dayyeh, Barham K., Wong Kee Song, Louis M., Larson, Mark V., Bruining, David H., Coelho-Prabhu, Nayantara, Buttar, Navtej S., Sedlack, Robert E., Chandrasekhara, Vinay, Leggett, Cadman L., Law, Ryan J., Rajan, Elizabeth, Gleeson, Ferga C., Alexander, Jeffrey A., and Storm, Andrew C.

Published
2024
Full Text
View/download PDF

6. Lumen-apposing metal stents for the treatment of benign gastrointestinal tract strictures: a single-center experience and proposed treatment algorithm

Author

Mahmoud, Tala, Beran, Azizullah, Bazerbachi, Fateh, Matar, Reem, Jaruvongvanich, Veeravich, Razzak, Farah Abdul, Abboud, Donna Maria, Vargas, Eric J., Martin, John A., Kellogg, Todd A., Ghanem, Omar M., Petersen, Bret T., Levy, Michael J., Law, Ryan J., Chandrasekhara, Vinay, Storm, Andrew C., Wong Kee Song, Louis M., Buttar, Navtej S., and Abu Dayyeh, Barham K.

Published
2023
Full Text
View/download PDF

11. Novel through-the-scope suture closure of colonic EMR defects (with video)

Author

Bi, Danse, Zhang, Linda Y., Alqaisieh, Mohammad, Shrigiriwar, Apurva, Farha, Jad, Mahmoud, Tala, Akiki, Karl, Almario, Jose Antonio, Shah-Khan, Sardar M., Gordon, Stuart R., Adler, Jeffrey M., Radetic, Mark, Draganov, Peter V., David, Yakira N., Shinn, Brianna, Mohammed, Zahraa, Schlachterman, Alexander, Yuen, Sofia, Al-Taee, Ahmad, Yunseok, Namn, Trasolini, Roberto, Bejjani, Michael, Ghandour, Bachir, Ramberan, Hemchand, Canakis, Andrew, Ngamruengphong, Saowanee, Storm, Andrew C., Singh, Shailendra, Pohl, Heiko, Bucobo, Juan Carlos, Buscaglia, Jonathan M., D’Souza, Lionel S., Qumseya, Bashar, Kumta, Nikhil A., Kumar, Anand, Haber, Gregory B., Aihara, Hiroyuki, Sawhney, Mandeep, Kim, Raymond, Berzin, Tyler M., and Khashab, Mouen A.

Published
2023
Full Text
View/download PDF

12. Esophageal and gastric malignancies after bariatric surgery: a retrospective global study

Author

Gallardo, Carlos Sosa, Agustin, Cataldo, Wright, Fernando, Fuente, Ignacio, Carbajo, Miguel, Cal, Patricio, Chisholm, Jacob, Kow, Lilian, Tan, Michael H.L., Gan, Philip, Gananadha, Sivakumar, Felsenreich, Daniel M., Prager, Gerhard, Matthys, Chris, Himpens, Jacques M., Focquet, Marc A.M.R.M., Ramos, Almino, Nato, Manoel Galvano, Vidal, Thiago, Andalib, Amin, Siblini, Aya, Ferri, Lorenzo, Abdarabo, Lina, Nevo, Yehonatan, Pescarus, Radu, Yang, Wah, Hamed, Hosam, Liagre, Arnaud, Bergeat, Damien, Marie, De Montrichard, Martini, Francesco, Regis, François, Genser, Laurent, Skalli, Mehdi, Nedelcu, Marius, Smejkal, Milan, Kassir, Radwan, Nicolas, Regenet, Stier, Christine, Nedelcut, Dan-Sebastian, Christodoulidis, Grigorios, Vennapusa, Amar, Kermansaravi, Mohammad, Raziel, Asnat, Sakran, Nasser, Oldani, Alberto, Boru, Cristian Eugeniu, Mécheri, Fouzia, Ciccarese, Francesca, Cesana, Giovanni Carlo, Musella, Mario, Uccelli, Matteo, Foletto, Mirto, Auricchio, Pasquale, Olmi, Stefano, Seki, Yosuke, Kasteleijn, Anne, Van 'T Hof, Gerhard, Apers, Jan A., Hart, Judith W.H., Van De Sande, Justin S.L., Takkenberg, Marijn, Feskens, Pierre B.G.M., Snoekx, Rob, Plat, Victor D., Sandvik, Jorunn, Kalinowski, Piotr, Nabais, Celso, Al-Bahrani, Ahmed Z., Al Zoubi, Mohammad, Bettonica, Carla, Osorio, Javier, Tejedor-Tejada, Javier, Sanz, Lourdes M., Cuadrado, Marta, Moorjani, Rajesh Gianchandani, Yannick, Fringeli, Suter, Michel, Borbély, Yves, Joerg, Zehetner, Barajas-Gamboa, Juan S., Kroh, Matthew, Kisiel, Aaron P., Kamocka, Anna, Immanuel, Arul, Sgromo, Bruno, Gopinath, Bussa, Khoo, David, Mukherjee, Samrat, Pournaras, Dimitrios, Underwood, Tim, Griffiths, Ewen A., Miller, Glenn V., Jaretzke, Helen, Dmitrewski, Jan, Wadley, Martin S., Al-Housni, Ragad, Gillies, Richard S., Singhal, Rishi, Preston, Shaun R., Robinson, Steven John, Hawkins, William J., Adamo, Marco, El Kalaawy, Mohamed, Gossage, James, Crawford, Christopher B., Jaruvongvanich, Veeravich, Parmar, Chetan, Zakeri, Roxanna, Abouelazayem, Mohamed, Shin, Thomas H., Aminian, Ali, Mahmoud, Tala, Abu Dayyeh, Barham K., Wee, Melissa Y., Fischer, Laura, Daams, Freek, and Mahawar, Kamal

Published
2022
Full Text
View/download PDF

13. Initial multicenter experience using a novel endoscopic tack and suture system for challenging GI defect closure and stent fixation (with video)

Author

Mahmoud, Tala, Wong Kee Song, Louis M., Stavropoulos, Stavros N., Alansari, Tarek H., Ramberan, Hemchand, Fukami, Norio, Marya, Neil B., Rau, Prashanth, Marshall, Christopher, Ghandour, Bachir, Bejjani, Michael, Khashab, Mouen A., Haber, Gregory B., Aihara, Hiroyuki, Antillon-Galdamez, Mainor R., Chandrasekhara, Vinay, Abu Dayyeh, Barham K., and Storm, Andrew C.

Published
2022
Full Text
View/download PDF

22. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure.

Author

AlKhatry, Maryam, Rapaka, Babusai, Maselli, Daniel B., Abboud, Donna Maria, Brunaldi, Vitor O., Mahmoud, Tala, Ghazi, Rabih, Abdul Razzak, Farah, Gala, Khushboo, Joudah, Imad, Housen, Fedaa, Al Qadi, Sana, Vargas, Eric J., Storm, Andrew C., and Abu Dayyeh, Barham K.

Subjects
NON-alcoholic fatty liver disease, ASPARTATE aminotransferase, FATTY liver, BARIATRIC surgery, INSULIN resistance, HEPATIC fibrosis
Abstract

Finally, given that most improvements in NAFLD were correlated with amelioration in obesity-related outcomes, it is unclear whether POSE 2.0 would be helpful for nonobese NAFLD patients. Measures of obesity, insulin resistance, and patient-reported outcomes In the POSE 2.0 arm, mean BMI improved from 37.9 kg/m SP 2 sp (95 %CI 36.7 to 39.1) at baseline to 31.6 kg/m SP 2 sp (95 %CI 29.1 to 33.5) at 12 months ( I P i < 0.001) ( B Table 3 s b ). Graph Introduction Nonalcoholic fatty liver disease (NAFLD) continues to rise as a common cause of chronic liver disease globally [1]. All patients experienced stable or improved fibrosis stages in both arms at 6 and 12 months, except for one patient in the POSE 2.0 arm who experienced worsening of fibrosis from 4.8 kPa (F0-F1) to 8.3 kPa (F3) at 12 months (Table 1). [Extracted from the article]

Published
2023
Full Text
View/download PDF

30. Novel classification system for walled-off necrosis: a step toward standardized nomenclature and risk-stratification framework.

Author

Baroud, Serge, Chandrasekhara, Vinay, Storm, Andrew C., Law, Ryan J., Vargas, Eric J., Levy, Michael J., Mahmoud, Tala, Bazerbachi, Fateh, Bofill-Garcia, Aliana, Ghazi, Rabih, Maselli, Daniel B., Martin, John A., Vege, Santhi Swaroop, Takahashi, Naoki, Petersen, Bret T., Topazian, Mark D., and Abu Dayyeh, Barham K.

Abstract

The optimal therapeutic approach for walled-off necrosis (WON) is not fully understood, given the lack of a validated classification system. We propose a novel and robust classification system based on radiologic and clinical factors to standardize the nomenclature, provide a framework to guide comparative effectiveness trials, and inform the optimal WON interventional approach. This was a retrospective analysis of patients who underwent endoscopic management of WON by lumen-apposing metal stent placement at a tertiary referral center. Patients were classified according to the proposed QNI classification system: quadrant ("Q"), represented an abdominal quadrant distribution; necrosis ("N"), denoted by the percentage of necrosis of WON; and infection ("I"), denoted as positive blood culture and/or systemic inflammatory response syndrome reaction with a positive WON culture. Two blinded reviewers classified all patients according to the QNI system. Patients were then divided into 2 groups: those with a lower QNI stratification (≤2 quadrants and ≤30% necrosis; group 1) and those with a higher stratification (≥3 quadrants, 2 quadrants with ≥30% necrosis, or 1 quadrant with >60% necrosis and infection; group 2). The primary outcome was mean time to WON resolution. Secondary procedural and clinical outcomes between the groups were compared. Seventy-one patients (75% men) were included and stratified by the QNI classification; group 1 comprised 17 patients and group 2, 54 patients. Patients in group 2 had a higher number of necrosectomies, longer hospital stays, and more readmissions. The mean time to resolution was longer in group 2 than in group 1 (79.6 ± 7.76 days vs 48.4 ± 9.22 days, P =.02). The mortality rate was higher in group 2 (15% vs 0%, P =.18). Despite the heterogeneous nature of WON in severe acute pancreatitis, a proposed QNI system may provide a standardized framework for WON classification to inform clinical trials, risk-stratify the disease course, and potentially inform an optimal management approach. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

32. Future of Metabolic Endoscopy.

Author

Ghazi, Rabih, Vargas, Eric J., Abboud, Donna, Abdul Razak, Farah, Mahmoud, Tala, Storm, Andrew C., Chandrasekhara, Vinay, and Abu Dayyeh, Barham K.

Subjects
WEIGHT loss, ENDOSCOPY, CONSERVATIVE treatment, BARIATRIC surgery, PUBLIC health
Abstract

Obesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost, safety concerns, and patient acceptance. In the past two decades, endoscopic bariatric and metabolic therapies (EBMTs) have emerged as safe, effective, and less invasive options for the treatment of obesity and its comorbidities, with recent studies reporting favorable outcomes in terms of weight loss and metabolic parameters. This article reviews the major and newly developed EBMTs, with emphasis on their metabolic effects and potential use in the management of metabolic conditions. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

36. Esophageal and gastric malignancies after bariatric surgery: a retrospective global study.

Author

Parmar, Chetan, Zakeri, Roxanna, Abouelazayem, Mohamed, Shin, Thomas H., Aminian, Ali, Mahmoud, Tala, Abu Dayyeh, Barham K., Wee, Melissa Y., Fischer, Laura, Daams, Freek, and Mahawar, Kamal

Abstract

Bariatric surgery can influence the presentation, diagnosis, and management of gastrointestinal cancers. Esophagogastric (EG) malignancies in patients who have had a prior bariatric procedure have not been fully characterized. To characterize EG malignancies after bariatric procedures. University Hospital, United Kingdom. We performed a retrospective, multicenter observational study of patients with EG malignancies after bariatric surgery to characterize this condition. This study includes 170 patients from 75 centers in 25 countries who underwent bariatric procedures between 1985 and 2020. At the time of the bariatric procedure, the mean age was 50.2 ± 10 years, and the mean weight 128.8 ± 28.9 kg. Women composed 57.3% (n = 98) of the population. Most (n = 64) patients underwent a Roux-en-Y gastric bypass (RYGB) followed by adjustable gastric band (AGB; n = 46) and sleeve gastrectomy (SG; n = 43). Time to cancer diagnosis after bariatric surgery was 9.5 ± 7.4 years, and mean weight at diagnosis was 87.4 ± 21.9 kg. The time lag was 5.9 ± 4.1 years after SG compared to 9.4 ± 7.1 years after RYGB and 10.5 ± 5.7 years after AGB. One third of patients presented with metastatic disease. The majority of tumors were adenocarcinoma (82.9%). Approximately 1 in 5 patients underwent palliative treatment from the outset. Time from diagnosis to mortality was under 1 year for most patients who died over the intervening period. The Oesophago-Gastric Malignancies After Obesity/Bariatric Surgery study presents the largest series to date of patients developing EG malignancies after bariatric surgery and attempts to characterize this condition. ▪ This is the largest series of patients developing OG cancer after bariatric surgery. ▪ OG cancers were diagnosed at a mean of 9.5 ± 7.4 years (range 1 – 44 years) from BS. ▪ One-third of the patients presented with distant metastasis at the time of diagnosis. ▪ Approximately 1 in 5 patients underwent palliative treatment. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

39. OUTCOMES OF EUS-GUIDED GASTROENTEROSTOMY VERSUS SURGICAL GASTROENTEROSTOMY AND ENTERAL STENTING FOR GASTRIC OUTLET OBSTRUCTION: A LARGE TWO-CENTER INTERNATIONAL STUDY.

Author

Jaruvongvanich, Veeravich, Mahmoud, Tala, Abu Dayyeh, Barham K., Chandrasekhara, Vinay, Law, Ryan, Levy, Michael J., Storm, Andrew C., Vargas, Eric J., Marya, Neil B., Abboud, Donna Maria, Ghazi, Rabih, Matar, Reem, Rapaka, Babusai, Buttar, Navtej S., Truty, Mark J., Reynaert, Hendrik, Messaoudi, Nouredin, Aerts, Maridi, and Kunda, Rastislav

Published
2022
Full Text
View/download PDF

40. USE OF A NOVEL THROUGH-THE-SCOPE ENDOSCOPIC TACK AND SUTURE DEVICE FOR STENT FIXATION: AN INITIAL MULTICENTER EXPERIENCE.

Author

Mahmoud, Tala, Akiki, Karl, Alqaisieh, Mohammad, Mitsuhashi, Shuji, Shinn, Brianna, Agnihotri, Abhishek, Chiang, Austin, Schlachterman, Alexander, Loren, David E., Kowalski, Thomas E., Kumar, Anand, Trasolini, Roberto P., Berzin, Tyler M., Al-Taee, Ahmad, Yunseok, Namn, Saraceni, Mark, Burkhard, Philip J., Yuen, Sofia, Haber, Gregory B., and Ramberan, Hemchand

Published
2022
Full Text
View/download PDF

45. IMPROVEMENTS IN HEPATIC STEATOSIS, OBESITY, AND INSULIN-RESISTANCE IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE UNDERGOING THE PRIMARY OBESITY SURGERY ENDOLUMINAL 2.0 (POSE 2.0) PROCEDURE: RESULTS FROM A PROSPECTIVE, CONTROLLED PRAGMATIC STUDY.

Author

Alkhatry, Maryam, Rapaka, Babusai, Maselli, Daniel B., Mahmoud, Tala, Ghazi, Rabih, Abboud, Donna Maria, Vargas, Eric J., Zaiter, Imad, Housen, Fedaa, Al Qadi, Sana, Alshehy, Shaikha S., Almehri, Sheikha H., Austria, Mary Jane P., Nair, Binu C., Puthiyapurayil, Nisha, Penol, Katherine Jan E., Storm, Andrew C., and Abu Dayyeh, Barham K.

Published
2022
Full Text
View/download PDF

47. ID: 3524461 VALIDATED CLINICAL PREDICTORS OF ENDOSCOPIC ULTRASOUND IN EVALUATING INCIDENTAL, ASYMPTOMATIC COMMON BILE DUCT DILATION ON IMAGING WITH NORMAL LIVER FUNCTION TESTS.

Author

Raza, Zain, Altayar, Osama, Mahmoud, Tala, Hasak, Stephen, Abusaleh, Rami, Ghazi, Rabih, Mullady, Daniel, Early, Dayna, Cosgrove, Natalie D., Kushnir, Vladimir, Lang, Gabriel, Sloan, Ian, Hollander, Thomas, Rajan, Elizabeth, Gleeson, Ferga C., Levy, Michael J., Storm, Andrew C., Abu Dayyeh, Barham K., Chandrasekhara, Vinay, and Das, Koushik K.

Published
2021
Full Text
View/download PDF

48. ID: 3526790 ERCP APPROACH FOR PATIENTS WITH A RYGB: A COMPARATIVE RETROSPECTIVE STUDY BETWEEN FOUR ERCP TECHNIQUES WITH PROPOSED MANAGEMENT APPROACH.

Author

Ghazi, Rabih, Jaruvongvanich, Veeravich, Baroud, Serge, Vargas, Eric J., Abusaleh, Rami, Mahmoud, Tala, Maselli, Daniel B., Storm, Andrew C., Sawas, Tarek, Kellogg, Todd A., omar ghanem, Levy, Michael J., Topazian, Mark, Law, Ryan, Martin, John A., Petersen, Bret T., Chandrasekhara, Vinay, and Abu Dayyeh, Barham K.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results